Gencell Ltd
GNCLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16 | $33 | $58 | $319 |
| - Cash | $12 | $5 | $11 | $12 |
| + Debt | $3 | $9 | $8 | $9 |
| Enterprise Value | $7 | $37 | $55 | $316 |
| Revenue | $10 | $5 | $7 | $6 |
| % Growth | 96.3% | -34.3% | 28.5% | – |
| Gross Profit | -$1 | -$5 | -$3 | -$4 |
| % Margin | -9.9% | -106.3% | -34.2% | -75.9% |
| EBITDA | -$18 | -$27 | -$33 | -$19 |
| % Margin | -184.4% | -544.9% | -452.4% | -335.8% |
| Net Income | -$19 | -$28 | -$37 | -$21 |
| % Margin | -203.5% | -581.9% | -495.4% | -366.1% |
| EPS Diluted | -0.18 | -0.26 | -0.34 | -0.22 |
| % Growth | 30.8% | 23.5% | -54.5% | – |
| Operating Cash Flow | -$18 | -$25 | -$21 | -$11 |
| Capital Expenditures | -$1 | -$2 | -$7 | -$8 |
| Free Cash Flow | -$19 | -$27 | -$28 | -$19 |